These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


104 related items for PubMed ID: 21213356

  • 1. The effects of commercial preparations of herbal supplements commonly used by women on the biotransformation of fluorogenic substrates by human cytochromes P450.
    Ho SH, Singh M, Holloway AC, Crankshaw DJ.
    Phytother Res; 2011 Jul; 25(7):983-9. PubMed ID: 21213356
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of human drug metabolizing cytochrome P450 enzymes by plant isoquinoline alkaloids.
    Salminen KA, Meyer A, Jerabkova L, Korhonen LE, Rahnasto M, Juvonen RO, Imming P, Raunio H.
    Phytomedicine; 2011 Apr 15; 18(6):533-8. PubMed ID: 20851588
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of human cytochrome P450 isoforms and NADPH-CYP reductase in vitro by 15 herbal medicines, including Epimedii herba.
    Liu KH, Kim MJ, Jeon BH, Shon JH, Cha IJ, Cho KH, Lee SS, Shin JG.
    J Clin Pharm Ther; 2006 Feb 15; 31(1):83-91. PubMed ID: 16476124
    [Abstract] [Full Text] [Related]

  • 4. In vitro inhibitory effects of Wen-pi-tang-Hab-Wu-ling-san on human cytochrome P450 isoforms.
    Lee HW, Kim DW, Phapale PB, Lim MS, Park J, Seo JJ, Park KM, Park YK, Yoon YR.
    J Clin Pharm Ther; 2011 Aug 15; 36(4):496-503. PubMed ID: 21729114
    [Abstract] [Full Text] [Related]

  • 5. Identification of human cytochrome P450 and flavin-containing monooxygenase enzymes involved in the metabolism of lorcaserin, a novel selective human 5-hydroxytryptamine 2C agonist.
    Usmani KA, Chen WG, Sadeque AJ.
    Drug Metab Dispos; 2012 Apr 15; 40(4):761-71. PubMed ID: 22266842
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes.
    Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Khan IA, Shah A.
    Clin Pharmacol Ther; 2005 May 15; 77(5):415-26. PubMed ID: 15900287
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. An in vitro evaluation of cytochrome P450 inhibition and P-glycoprotein interaction with goldenseal, Ginkgo biloba, grape seed, milk thistle, and ginseng extracts and their constituents.
    Etheridge AS, Black SR, Patel PR, So J, Mathews JM.
    Planta Med; 2007 Jul 15; 73(8):731-41. PubMed ID: 17611934
    [Abstract] [Full Text] [Related]

  • 11. Interactions of herbs with cytochrome P450.
    Zhou S, Gao Y, Jiang W, Huang M, Xu A, Paxton JW.
    Drug Metab Rev; 2003 Feb 15; 35(1):35-98. PubMed ID: 12635815
    [Abstract] [Full Text] [Related]

  • 12. The interaction potential of herbal medicinal products: a luminescence-based screening platform assessing effects on cytochrome P450 and its use with devil's claw (Harpagophyti radix) preparations.
    Modarai M, Suter A, Kortenkamp A, Heinrich M.
    J Pharm Pharmacol; 2011 Mar 15; 63(3):429-38. PubMed ID: 21749392
    [Abstract] [Full Text] [Related]

  • 13. Screening of medicinal plants for possible herb-drug interactions through modulating nuclear receptors, drug-metabolizing enzymes and transporters.
    Husain I, Dale OR, Martin K, Gurley BJ, Adams SJ, Avula B, Chittiboyina AG, Khan IA, Khan SI.
    J Ethnopharmacol; 2023 Jan 30; 301():115822. PubMed ID: 36223846
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Rapid characterization of the major drug-metabolizing human hepatic cytochrome P-450 enzymes expressed in Escherichia coli.
    McGinnity DF, Griffin SJ, Moody GC, Voice M, Hanlon S, Friedberg T, Riley RJ.
    Drug Metab Dispos; 1999 Sep 30; 27(9):1017-23. PubMed ID: 10460801
    [Abstract] [Full Text] [Related]

  • 16. Drug-herb interactions with herbal medicines for menopause.
    Huntley A.
    J Br Menopause Soc; 2004 Dec 30; 10(4):162-5. PubMed ID: 15667753
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of cytotoxic, genotoxic and CYP450 enzymatic competition effects of Tanzanian plant extracts traditionally used for treatment of fungal infections.
    van den Bout-van den Beukel CJ, Hamza OJ, Moshi MJ, Matee MI, Mikx F, Burger DM, Koopmans PP, Verweij PE, Schoonen WG, van der Ven AJ.
    Basic Clin Pharmacol Toxicol; 2008 Jun 30; 102(6):515-26. PubMed ID: 18331392
    [Abstract] [Full Text] [Related]

  • 18. Assessment of extracts from mistletoe (Viscum album) for herb-drug interaction by inhibition and induction of cytochrome P450 activities.
    Doehmer J, Eisenbraun J.
    Phytother Res; 2012 Jan 30; 26(1):11-7. PubMed ID: 21538623
    [Abstract] [Full Text] [Related]

  • 19. In vitro inhibition of Huanglian [Rhizoma coptidis (L.)] and its six active alkaloids on six cytochrome P450 isoforms in human liver microsomes.
    Han YL, Yu HL, Li D, Meng XL, Zhou ZY, Yu Q, Zhang XY, Wang FJ, Guo C.
    Phytother Res; 2011 Nov 30; 25(11):1660-5. PubMed ID: 21425377
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.